Moreover, TP53 was found significantly co-expressed with H2AFZ in TP53 mutants, suggesting that TP53 mutation might be a regulatory event of H2AFZ expression in HCC. This evidence concerns the gene H2AZ2 and hepatocellular carcinoma.